Optimizing Drug Discovery
Our ultra-large virtual screening platform is capable of screening over 60 billion compounds
Revolutionizing drug discovery
Virtual Discovery is a Massachusetts based biotech company that utilizes technology developed in the Harvard Wagner Lab to carry out ultra-large virtual screenings.
Our mission is to help pharmaceutical companies discover new and effective therapeutics using our dramatically faster and cheaper molecule-screening capabilities.
WHAT WE OFFER
HIT IDENTIFICATION
We discover potent hit and lead compounds using ultra-large virtual screenings (on the order of billions of small molecules)
LEAD IDENTIFICATION
We optimize hit and lead compounds by screening hundreds of thousands of analogs against a specific target
Our Services
Unprecedented Speed.
High-quality hits.
Magnitudes cheaper than traditional wet-lab methods.
Our Technology
We use VirtualFlow (Nature 2020) to carry out the largest virtual screenings in the world. We are able to screen against a variety of compound libraries—including the REAL library by Enamine, which contains more than 1.2 billion compounds.
Because we can explore the chemical space far more thoroughly than traditional methods, we produce hits with better binding affinity and other ADMET related properties.
Contact Us
